08/04/2025
3:30 PM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2025
6:44 PM | BlackRock, Inc. (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/26/2025
6:08 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
4:31 PM | CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
| Form 3/A | |
06/06/2025
4:38 PM | Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:47 PM | CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:20 PM | CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Fardis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CRSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Rommel Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:30 PM | CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:45 PM | CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:45 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
9:52 AM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
4:53 PM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/24/2025
4:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:05 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:05 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:05 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
10:23 AM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
8:23 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/27/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
12:34 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
11/05/2024
8:05 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
8:10 AM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
5:00 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
5:00 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
5:45 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
